Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Bioneim Biotechnology is a specialized biotechnology company focused on the research, development, and large-scale production of high-value health ingredients through advanced microbial fermentation. The company's core product portfolio includes Vitamin K2 (as MK-7), Coenzyme Q10, Pyrroloquinoline Quinone (PQQ), Sialic Acid, and Ectoine, catering to the global nutraceutical, pharmaceutical, and cosmetic industries. Bioneim leverages its proprietary fermentation technology to ensure high purity and bioavailability of its ingredients, positioning itself as a key supplier in the functional food and supplement markets. With a focus on green manufacturing and innovation, the company operates state-of-the-art facilities that comply with international quality standards such as GMP and ISO. Their products are primarily aimed at improving bone health, cardiovascular function, and skin protection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Bioneim Biotechnology.